Digital Biomarkers Becoming Integral to Precision Medicine
In a new commentary for Pharmaceutical Market Europe, Precision for Value’s Austin Speier, VP, Emerging Technology, examines the promise and advantages of integrating digital biomarkers into precision medicine. (more…)
PHE Expert Shafrin: Make Real-World Evidence the New Gold Standard
In an in-depth commentary for Pharmaceutical Market Europe, senior economist Jason Shafrin argues for real-world evidence (RWE) to become the “gold standard” of scientific evidence and heath technology assessments. (more…)
Precision Biomarker Data Management Expansion Detailed in GenomeWeb
In its weekly digest, GenomeWeb reports on Precision for Medicine’s expansion of biomarker data management and translational informatics services. (more…)
Precision Oncology’s Messerschmidt Discusses Cancer Vaccine Development in Biocompare
Chief Medical Officer Gerry Messerschmidt authors a new commentary in Biocompare outlining critical success factors toward cancer vaccine development. (more…)
Precision Payer Expert: Focus on Drug Pricing Here to Stay
Jeremy Schafer, director of Precision’s Payer Access Solutions, contributes his perspectives on drug pricing in a PharmaVOICE feature article. (more…)